How do you approach imaging in patients with M0 castration-resistant prostate cancer with rising PSA on an ARSI?
What imaging modality do you use (conventional, PSMA PET, etc.)? When do you image (ex: a PSA threshold or PSADT)?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · The University of Texas Health Science Center at San Antonio
Answered on
I do not use molecular imaging (e.g., PSMA-PET/CT) for patients with CRPC (including both mCRPC and nmCRPC) except as a screening tool for Pluvicto eligibility for three reasons.
- Most patients have metastasis already. In one study that used molecular imaging in patients with nmCRPC, they identified ...
Join for free or sign in to see the full answer